β¨ Medicines Consent and Justice Notices
NEW ZEALAND GAZETTE, No. 61
7 JUNE 2007
1631
Schedule
Product:
Avelox IV 400
Active Ingredient:
Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Bayer New Zealand Limited
Manufacturers:
Bayer Healthcare AG, Bayerwerk, Germany
Fresenius Kabi Norge AS, Halden, Norway
Product:
Avelox
Active Ingredient:
Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bayer New Zealand Limited
Manufacturer:
Bayer Healthcare AG, Bayerwerk, Germany
Product:
Fucidin
Active Ingredient:
Sodium fusidate 250mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
CSL Biotherapies (NZ) Limited
Manufacturer:
Laboratoires Leo SA, Vernouillet, France
Product:
Somatuline Autogel
Active Ingredient:
Lanreotide 24.6%w/w
Dosage Form:
Solution for injection
New Zealand Sponsor:
New Zealand Medical & Scientific Limited
Manufacturers:
Beaufour Ipsen Industrie, Dreux, France
Ipsen Pharma Biotech, Signes, France
Dated this 31st day of May 2007.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go3793
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Copaxone
Active Ingredient:
Glatiramer acetate 20mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturers:
Baxter Pharmaceutical Solutions LLC, Bloomington, Indiana, United States of America
Teva Pharmaceutical Industries Limited, (Ikapharm), Kfar Saba, Israel
Note: This consent is valid for two years from 13 October 2007.
Product:
Copaxone
Active Ingredient:
Glatiramer acetate 20mg
Dosage Form:
Powder for injection
Diluent
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Teva Pharmaceutical Industries Limited, (Ikapharm), Kfar Saba, Israel
Note: This consent is valid for two years from 24 May 2007.
Dated this 31st day of May 2007.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go3792
Justice
Justices of the Peace Act 1957
Justice of the Peace Resignations
Arthur Frank Rapley, of Rangiora
Stephen Walter Goodenough, of Christchurch
have resigned their appointments as Justices of the Peace for New Zealand.
Dated at Wellington this 5th day of June 2007.
BELINDA CLARK, Secretary for Justice.
go3856
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 61
Gazette.govt.nz —
NZ Gazette 2007, No 61
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare31 May 2007
Medicines, Consent, Distribution, Avelox, Fucidin, Somatuline Autogel
- DON MATHESON, Deputy Director-General, Public Health
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare31 May 2007
Medicines, Provisional Consent, Renewal, Copaxone
- DON MATHESON, Deputy Director-General, Public Health
βοΈ Justice of the Peace Resignations
βοΈ Justice & Law Enforcement5 June 2007
Justices of the Peace, Resignations, Rangiora, Christchurch
- Arthur Frank Rapley, Resigned as Justice of the Peace
- Stephen Walter Goodenough, Resigned as Justice of the Peace
- BELINDA CLARK, Secretary for Justice